Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
DA.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
AY.68 (Delta)NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BQ.1.1.14NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.1.16.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
DN.1.1.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.160.28NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
AY.5.2 (Delta)NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
DN.1.1.4NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.1.4NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
AY.84 (Delta)NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.213NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
AY.56 (Delta)NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
AY.39.1.4NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
AY.4.14 (Delta)NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.359NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BN.1.5.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.2.66NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.485NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
CP.3NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.177.73NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
AY.112.2 (Delta)NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.13NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
Q.8 (Alpha)NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
AY.122.1 (Delta)NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.3.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
AY.5.6 (Delta)NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.440NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.177.25NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
AY.23.2 (Delta)NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
AY.104 (Delta)NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.198NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
EG.1.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
XAFNWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BC.2NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
P.1.17.1 (Gamma)NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.2.3.16NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.177.41NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.375NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BL.1.4NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
CP.1.3NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
FC.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BY.1.2NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BF.7.17NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
AY.123 (Delta)NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BQ.1.27NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.2.12.2NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
DN.1.1.3NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.177.51NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BF.17NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.2.28NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used